Rojo, Federico
Conde, Esther
Torres, Héctor
Cabezón-Gutiérrez, Luis
Bautista, Dolores
Ramos, Inmaculada
Carcedo, David
Arrabal, Natalia
García, J. Francisco
Galán, Raquel
Nadal, Ernest
Article History
Received: 22 November 2021
Accepted: 8 March 2022
First Online: 19 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: FR received research grant support from Pfizer and Roche and received speaker or consulting fees from Roche, BMS, MSD, Merck, Novartis, Pfizer, AstraZeneca, Genomic Health, Bayer. EC received research grant support from Lilly, Roche and Thermo Fischer, and received speaker or consulting fees from Astra Zeneca, BMS, Lilly, MSD, Pfizer, Roche and Takeda. HT received grants from Roche and AstraZeneca. LCG received speaker or consulting fees from Angelini, Grunenthal, Kyowa Kirin, Mudipharma, Pfizer, Roche, Rovi, Leo Pharma, Merck Serono, Ipsen Pharma, Lilly, Amgen, Boehringer Ingelheim, and AstraZeneca. DB received research support from Roche and AstraZeneca, participated in advisory boards for MSD, Roche, AstraZeneca and Abbie, and received speaker fees from Roche, MSD and AstraZeneca. IR declared that she has no competing interest. EN received research grant support from Pfizer, Roche, Bristol Myers Squibb and Merck Serono and participated in advisory boards or gave lectures for BMS, MSD, Lilly, Roche, Pfizer, Takeda, Boehringer Ingelheim, Amgen, Merck Serono, Sanofi, Bayer and AstraZeneca. NA, JFG and RG are employees of Roche. DC is employee of Hygeia Consulting which received funding from Roche to conduct the analysis.